Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Vland Biotech(603739) the Revenue is 364.57 M (+6.6%);the EBIT is 48.34 M (+92.4%);the EPS is 0.0799 (+14.88%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.36B6.60%
----
----
EBIT
0.05B92.40%
----
----
EPS
0.079914.88%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf